Thomas Reiser/LinkedIn
Nov 20, 2025, 13:42
Rebalancing Therapies Poised to Transform Hemophilia Care․ Explore the New ISTH CME
Thomas Reiser, Executive Director of the International Society on Thrombosis and Haemostasis (ISTH), shared on X:
” New ISTH CME activity available:
Rebalancing Therapies for Hemophilia Are You Ready?
Gain the latest insights on emerg. rebalancing treatments, compare evolving clin. profiles & learn how to prepare your team for what’s next in hemophilia care.”
Read more here.
Stay updated with Hemostasis Today.
-
May 26, 2026, 16:45Ashley George: Take the Leap for Thrombosis UK
-
May 26, 2026, 16:40Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications
-
May 26, 2026, 15:32Haroun Gajraj: Brown Marks After Microsclerotherapy – What Every Practitioner Needs to Know
-
May 26, 2026, 15:29Jacqueline van Paassen: Lack of Essential Clinical Data in DOAC Prescriptions in Community Pharmacies
-
May 26, 2026, 15:22Shazmah Shaikh: One Visual Guide to Understand All Major Anticoagulants
-
May 26, 2026, 14:39Chidinma Favour։ Welcome to Day 25 of My 31-Day Stroke Awareness Series
-
May 26, 2026, 14:35Novel Insights Into Congenital and Acquired Coagulopathies – ICHCC
-
May 26, 2026, 14:24Fernanda Orsi: The Growing Impact of Hematology Research in Latin America
-
May 26, 2026, 14:23Rense Buijvoets: What If Clots Could Be Treated Exactly Where They Form?